drugset / Trial / NCT05707754
Sphenopalatine Ganglion Block Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to compare the administration and dosage of bupivacaine for sphenopalatine ganglion (SPG) nerve block. The main question\[s\] it aims to answer are: * Does a high dose (3ml) give more relief than a low dose (1ml)? * Does bilateral administration give more relief than unilateral? Participants with headaches will be asked to lie down and have SPG block performed. Researchers will compare dosage and administration to see how symptoms are reduced.
Timeline
- Start
- 2023-03-06
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 1 ml | Topical |
| Comparator | Bupivacaine | Other / unclassified | 3 ml | Topical |
Indications
No indication recorded.